Aurinia Pharmaceuticals Inc.

AUPH ·Healthcare, Drug Manufacturers - General, Alberta, Canada
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 11, 2026 FORM 4
SCHEDULE 13D/A Aug 26, 2026
4 Aug 25, 2026 FORM 4
144 Aug 21, 2026
8-K Aug 19, 2026 8-K
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jun 8, 2026 FORM 4
4 Jun 8, 2026 FORM 4
4 Jun 8, 2026 FORM 4
4 Jun 8, 2026 FORM 4
144 Jun 5, 2026
SCHEDULE 13D/A Jun 4, 2026
8-K Jun 4, 2026 8-K
144 Jun 4, 2026
4 Jun 2, 2026
144 Jun 2, 2026
4 May 20, 2026 FORM 4
4 May 20, 2026 FORM 4
4 May 20, 2026 FORM 4
144 May 11, 2026
144 May 11, 2026
144 May 11, 2026
8-K May 11, 2026 8-K
SC TO-T/A May 11, 2026 SC TO-T/A
← Newer Page 1 of 25 · 613 filings Older →